• SP2509 (SKU B4894): Precision LSD1 Antagonist for AML Epigen

  2026-06-09

  This article provides a scenario-driven, evidence-based analysis of SP2509 (SKU B4894), a potent lysine-specific demethylase 1 antagonist for acute myeloid leukemia and cancer epigenetics research. By addressing real-world lab challenges in assay reproducibility, protocol design, and data interpretation, it demonstrates how SP2509 from APExBIO offers validated solutions for apoptosis induction and AML differentiation workflows.

• Structural Mechanisms of Odor Detection by Class II Olfactor

  2026-06-09

  Han et al. provide high-resolution cryo-EM structures of the class II olfactory receptor Olfr110 bound to hydrophobic fatty acid odorants. Their work elucidates a dual-pocket ligand recognition mechanism and an unconventional activation pathway, shedding light on odor detection and offering new avenues for drug discovery targeting olfactory GPCRs.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Protocol

  2026-06-08

  The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) prevents protein degradation during extraction, specifically addressing the need for mass spectrometry-compatible inhibition. It is best suited for workflows where AEBSF exclusion is critical for downstream MS analysis, but is not intended for applications requiring metalloproteinase inhibition unless EDTA is added separately.

• Meropenem Trihydrate in Phenotypic Resistance Profiling Rese

  2026-06-08

  Discover how Meropenem trihydrate advances phenotypic resistance profiling and metabolomic assay design for antibiotic resistance research. This article offers a distinct perspective, connecting LC-MS/MS insights with practical applications for robust experimental models.

• NU6300 Blocks Gasdermin D Activation via Cysteine-191 Modifi

  2026-06-07

  Jiang et al. report that NU6300 covalently binds to cysteine-191 of gasdermin D, inhibiting both its cleavage and palmitoylation to suppress pyroptosis in inflammatory models. This mechanistic advance refines the targeting of inflammasome-driven cell death and broadens the landscape for small-molecule GSDMD inhibitors.

• Phosbind Biotin: Advanced Phosphate Detection for Dynamic Si

  2026-06-06

  Explore how Phosbind Biotin enables precise dinuclear metal complex phosphate binding for advanced Western Blot detection of phosphorylated proteins. This article uncovers new assay strategies and mechanistic insights for dynamic signal transduction research.

• Nonivamide: Translating TRPV1 Modulation from Mechanism to C

  2026-06-05

  This thought-leadership article explores how Nonivamide, a capsaicin analog and selective TRPV1 agonist, is redefining translational research across oncology and neuroimmune inflammation. Bridging mechanistic insights with strategic guidance, we contextualize Nonivamide's impact on cancer cell growth, mitochondrial apoptosis, and anti-inflammatory pathways. We further highlight recent evidence for TRPV1-driven neuroimmune modulation, present actionable protocol parameters, and position Nonivamide as a next-generation tool in the competitive landscape. The piece escalates discourse beyond typical product profiles, providing a visionary outlook for researchers seeking reproducibility and clinical relevance.

• Meropenem Trihydrate: Protocols and Precision in Resistance

  2026-06-05

  Meropenem trihydrate from APExBIO empowers researchers to dissect bacterial resistance with reproducibility and clarity. This guide unpacks experimental workflows, advanced troubleshooting, and actionable metabolomics-driven strategies for tackling gram-negative and gram-positive pathogens in both classic and emerging models.

• Paroxetine Mesylate: Advanced SSRI Workflows and Oncology In

  2026-06-04

  Paroxetine Mesylate stands out by combining potent selective serotonin reuptake inhibition with multi-kinase activity, supporting workflows in neuropsychiatric, oncology, and translational cardiac biomarker research. This article details protocol optimizations and troubleshooting strategies that empower researchers to leverage its multi-domain efficacy for reproducible, high-impact results.

• EdU Imaging Kits (Cy3): Precision Proliferation Analysis in

  2026-06-04

  Explore how EdU Imaging Kits (Cy3) enable precise, artifact-free S-phase DNA synthesis measurement for advanced cell cycle research and developmental studies. Uncover unique assay design insights and reference-backed guidance for optimizing cell proliferation analysis.

• EZ Cap™ Firefly Luciferase mRNA: Setting New Standards for I

  2026-06-03

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables next-generation in vivo translation efficiency and bioluminescent reporter assays. This article uniquely connects engineered mRNA stability, practical delivery strategies, and evidence-based protocol optimization for molecular biology and imaging workflows.

• Disulfiram as a Dopamine β-Hydroxylase Inhibitor in Cancer R

  2026-06-03

  Disulfiram, long known for its anti-alcoholism application, is now an elite research tool for probing proteasome inhibition and apoptotic cancer cell death. This guide details robust experimental workflows, troubleshooting strategies, and highlights a synthetic lethality innovation for APC-deficient cancer, with practical insights for maximizing reproducibility using APExBIO’s Disulfiram.

• Troglitazone: PPARγ Agonist for Type 2 Diabetes & Tumor Mode

  2026-06-02

  Troglitazone is a well-characterized selective PPARγ/α agonist that modulates lipid and glucose metabolism, with established roles in type 2 diabetes research and emerging utility as an anti-tumor agent in renal carcinoma models. Its mechanism, benchmarks, and workflow parameters are tightly defined by peer-reviewed evidence and product documentation.

• Z-WEHD-FMK: Advanced Caspase Inhibition for Inflammation Res

  2026-06-02

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) stands out as a gold-standard irreversible caspase inhibitor, enabling precise dissection of inflammatory and pyroptotic pathways in cell models. This guide details protocol optimizations, troubleshooting, and real-world applications in apoptosis and infectious disease research, drawing on recent breakthroughs in the caspase signaling field.

• Protease and Phosphatase Inhibitor Cocktail: Mechanisms & Ev

  2026-06-01

  The Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) preserves protein integrity during extraction by blocking diverse proteases and phosphatases. Its EDTA-free formulation is essential for workflows sensitive to metal chelation. This article details its spectrum of action, evidence for efficacy, and best practices for use.

16271 records 1/1085 page Next 12345 下5页 Last page